📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Routes to 2-aminooxazolines using single and multistep enzymatic transformations

Lead Research Organisation: UNIVERSITY COLLEGE LONDON
Department Name: Chemistry

Abstract

This project aims to use enoyl reductase and transaminase native enzymes and mutants, together with other chemical or enzymatic steps (as single step or multi-enzyme pathways) to synthesise 2-aminooxazolines. The project will pave the way for the synthesis of such bioactive compounds in a sustainable fashion, cheaply and efficiently by biocatalysis in E. coli or other bacteria, under mild reactions conditions.

People

ORCID iD

Publications

10 25 50

Studentship Projects

Project Reference Relationship Related To Start End Student Name
BB/M009513/1 30/09/2015 31/03/2024
1758915 Studentship BB/M009513/1 30/09/2016 16/06/2021
 
Description With a growing interest in the pharmaceutical, fine chemical and agrochemical industry for environmentally benign and sustainable syntheses, biocatalysis has emerged as a forerunner in the field of green chemistry. Significant advantages over traditional chemical routes have been demonstrated, including high regio- and stereoselectivity under mild, non hazardous conditions, as well as high efficacy and cost-effectiveness. From this award, we have investigated the application of a one-pot enzymatic cascade utilising ene-reductases (ERs) and ?-transaminases (?-TAm) for the molecular assembly of optically-active 2-aminooxazolines employed as TAAR1 inhibitors. These TAAR1 agonists were recently patented for numerous neuropsychiatric disorders including depression, schizophrenia, and Parkinson's disease, amongst others.
Exploitation Route This funding has successfully developed the enzymatic cascade of ene-reductases (ERs) and ?-transaminases (?-TAm) as a cost effective and efficacious strategy for the generation of chiral synthons and bioactive molecules, surpassing many traditional synthetic chemistry approaches. Enantioenriched products afforded from this cascade offer high value chiral building blocks in agrochemical, pharmaceutical and fine chemical applications.
Sectors Agriculture

Food and Drink

Chemicals

Environment

Manufacturing

including Industrial Biotechology

Pharmaceuticals and Medical Biotechnology

 
Description Research from this award has been pursued with non-academic applications in mind. Findings have been positive, and research is ongoing. Thus, at this current stage potential economic and societal impacts are still being explored.